Clinical trials
Prospective Study clinical trials
Below are recruiting prospective study clinical trials, each written for real people, not researchers. We’re tracking 872 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03225586Recruiting
Study of health differences in urban and rural communities
This study enrolls consenting adults to understand how health differs between people living in cities versus rural areas. Your participation may help researchers learn what factors influence health over time.
Rosario, Santa Fe ProvinceAges 35–70 - NCT03980002RecruitingPhase 2
New treatment for CLL using alternating two drug types
This trial studies an approach for people with newly diagnosed CLL/SLL (chronic lymphocytic leukemia or related disease) who need treatment. It tests whether alternating two types of chemotherapy with ibrutinib (a targeted pill) can control the disease better and safely.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT04188808Recruiting
Study comparing patients with artery disease before surgery
This study looks at people with blocked leg arteries who are having planned (elective) open surgery for symptoms like leg pain when walking or at rest. It aims to better understand what to expect in these patients and how to compare outcomes between groups.
GothenburgAges Any age - NCT04330846Recruiting
Study of new narrowing in Crohn’s treated with two approaches
This study looks at treatments for a new (de novo) narrow area in the bowel from Crohn’s disease. It aims to see which treatment works better at relieving blockage-type symptoms for the safest, most effective option.
Badalona, BarcelonaAges 18–80 - NCT04371913Recruiting
Second chance breast-conserving treatment for certain breast recurrences
This trial studies a personalized plan to remove and re-treat a limited breast recurrence while trying to keep the breast. It may help people whose cancer came back in the same breast after prior breast-conserving treatment, with certain size and spread limits.
Brooklyn, New YorkAges 19–90 - NCT04682470Recruiting
Research study following young adults with cancer
This is an observational study that follows young adults with a confirmed cancer diagnosis to learn more about their experience and care. It does not test a new drug, but your information may help improve future cancer treatment and support.
Amsterdam, North HollandAges 18–39 - NCT04777916Recruiting
Study for adults with acute myeloid leukemia (AML)
This non-interventional study follows adults with acute myeloid leukemia (AML) to better understand the disease and how patients do in real-world care. It may help researchers compare outcomes across different types of AML, but you would not receive a study treatment just for joining.
AmiensAges 18 years+ - NCT05152472RecruitingPhase 2
Imatinib plus atezolizumab versus imatinib alone for advanced GIST
This Phase 2 trial tests whether adding atezolizumab (an immune medicine) to imatinib works better than imatinib by itself in people with advanced gastrointestinal stromal tumors (GIST) that can’t be fully removed and have progressed after standard treatments. It may help by improving how well tumors respond and how long disease stays under control.
Lyon, RhôneAges 18 years+ - NCT05164328Recruiting
Study of heart changes in endurance athletes
This study looks at how the heart can adapt in teens and young adults who do endurance sports. It may help doctors tell the difference between normal training-related heart changes and heart disease.
Melbourne, VictoriaAges 14–23 - NCT05681923Recruiting
Pregnancy study tracking how brain development risk may run in families
This study follows pregnant parents and their child to understand what factors influence early brain and development. It compares families with an autistic sibling (higher risk) to families without (lower risk) to spot patterns that may help future care.
MontpellierAges Any age - NCT05871164Recruiting
Long-term study of radiofrequency treatment for pancreatic tumors
This study follows adults over time who are treated for a pancreatic tumor using ultrasound-guided radiofrequency through a thin needle. It aims to understand what happens after treatment and how patients do, so future care can improve.
ToulonAges 18 years+ - NCT06032676Recruiting
Surgeons’ views on infant bowel disease decisions
This study interviews surgeons who treat infants with a serious bowel condition called necrotising enterocolitis (NEC). Researchers want to understand how surgeons make decisions and how babies do afterward.
Southampton, HampshireAges Up to 4 months - NCT06047782Recruiting
MRI study of atrial scarring and stroke risk
This study uses a special heart MRI to look for scarring in the upper chambers of the heart (atria) that might cause hidden atrial fibrillation after a stroke with no known cause. It may help explain why the stroke happened and guide future treatment.
DijonAges 18 years+ - NCT06078514Recruiting
Sexual health after first LEEP: a study
This study looks at how a common cervical procedure called LEEP affects your sexual health and quality of life. It follows women who need a LEEP for the first time to see how they feel afterward.
HelsinkiAges 18–70 - NCT06329999Recruiting
CMGV for recurrent AML and high-risk MDS
This study tests a new treatment called CMGV for adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) has returned or is not improving. It is for people who may be older or have had other blood disorders.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06339398Recruiting
Exercise dose and brain health in Parkinson's
This study looks at how different amounts of physical exercise affect brain chemicals, movement symptoms, and brain connections in people with Parkinson's disease. You would walk and do exercises while researchers track changes over time.
Cassino, FrosinoneAges 30–80 - NCT06397833Recruiting
Monitoring heart pressure after heart failure hospitalization
This study is testing a new wearable device (Acorai ICPM) that measures pressure inside your heart. The goal is to see if it can help predict how well you will do after being discharged from the hospital for heart failure.
Uxbridge, MiddlesexAges 18 years+ - NCT06500364RecruitingPhase 4
Knotless implants for hip capsule closure study
This study tests a new knotless device for closing the hip capsule during hip arthroscopy. It may help patients heal better after surgery.
Des Plaines, IllinoisAges 18–60 - NCT06519578Recruiting
Liver Cancer Study: Comparing Two Chemotherapy Drugs via Artery Infusion
This study compares two chemotherapy drugs (raltitrexed and 5-fluorouracil) given directly into the liver's main artery to treat liver cancer. It aims to see which drug works better and is safer for people with hepatocellular carcinoma.
ShanghaiAges 18–75 - NCT06538038Recruiting
Osimertinib plus chemo vs. osimertinib alone for EGFR-mutated NSCLC
This study compares two standard treatments for advanced lung cancer with an EGFR mutation: osimertinib alone versus osimertinib plus chemotherapy. It aims to see which approach works better and is not a trial of a new drug, so you can receive usual care while contributing data.
Birmingham, AlabamaAges 18 years+ - NCT06598046RecruitingPhase 2
Utidelone and Capecitabine for triple-negative breast cancer brain metastases
This trial tests a combination of two chemotherapy drugs (Utidelone and Capecitabine) for people with triple-negative breast cancer that has spread to the brain. The goal is to see if the combination can shrink or control the brain tumors.
Zhengzhou, HenanAges 18 years+ - NCT06635954Recruiting
Blood test to predict response to immunotherapy
This study is testing a blood test (Episwitch CiRT®) that looks at your DNA to see if it can predict whether you will respond to a type of immunotherapy called PD-(L)-1 checkpoint inhibitors. The goal is to see if this test is accurate across many different types of cancer.
Norwich, ConnecticutAges 18 years+ - NCT06699472RecruitingPhase 2
Study of trilaciclib to prevent low blood counts in Ewing's sarcoma chemotherapy
This trial tests whether the drug trilaciclib can reduce low blood cell counts caused by chemotherapy in people with Ewing's sarcoma. If you qualify, you may receive a medication that could help protect your bone marrow during treatment.
Shanghai, Shanghai MunicipalityAges 14–40 - NCT06709872Recruiting
Study to tell borderline from early ovarian cancer
This study uses ultrasound and blood tests to help doctors tell the difference between a borderline ovarian tumor and an early-stage invasive ovarian cancer. If you have a cyst found on your ovary that might be one of these types, joining could help improve diagnosis.
Leuven, Flemish BrabantAges 18 years+
Hear when a new Prospective Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prospective study?
- Yes. Clin2 currently lists 872 recruiting prospective study studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prospective study trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prospective study trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.